{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:03:30Z","timestamp":1759881810122,"version":"build-2065373602"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,6]]},"DOI":"10.7759\/cureus.93972","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:56:31Z","timestamp":1759794991000},"source":"Crossref","is-referenced-by-count":0,"title":["Serum Calcium as a Determinant of Fibroblast Growth Factor 23 Levels in Patients With Primary Hyperparathyroidism and Graves\u2019 Disease"],"prefix":"10.7759","author":[{"given":"Hiroyuki","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisakazu","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tatsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita T","year":"2000","unstructured":"Yamashita T, Yoshioka M, Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun. 2000, 277:494-8. 10.1006\/bbrc.2000.3696","journal-title":"Biochem Biophys Res Commun"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.27","article-title":"Phosphate and FGF-23","volume":"79","author":"J\u00fcppner H","year":"2011","unstructured":"J\u00fcppner H. Phosphate and FGF-23. Kidney Int Suppl. 2011, 79:S24-7. 10.1038\/ki.2011.27","journal-title":"Kidney Int Suppl"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-024-01317-x","article-title":"Treatment advances in tumor-induced osteomalacia","volume":"116","author":"Hartley IR","year":"2025","unstructured":"Hartley IR, Roszko KL. Treatment advances in tumor-induced osteomalacia. Calcif Tissue Int. 2025, 116:24. 10.1007\/s00223-024-01317-x","journal-title":"Calcif Tissue Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00293","article-title":"Hyperphosphatemic tumoral calcinosis: pathogenesis, clinical presentation, and challenges in management","volume":"11","author":"Boyce AM","year":"2020","unstructured":"Boyce AM, Lee AE, Roszko KL, Gafni RI. Hyperphosphatemic tumoral calcinosis: pathogenesis, clinical presentation, and challenges in management. Front Endocrinol (Lausanne). 2020, 11:293. 10.3389\/fendo.2020.00293","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00502.2004","article-title":"Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells","volume":"288","author":"Ito M","year":"2005","unstructured":"Ito M, Sakai Y, Furumoto M, et al.. Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells. Am J Physiol Endocrinol Metab. 2005, 288:E1101-9. 10.1152\/ajpendo.00502.2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10558","article-title":"FGF23 and vitamin D metabolism","volume":"5","author":"Latic N","year":"2021","unstructured":"Latic N, Erben RG. FGF23 and vitamin D metabolism. JBMR Plus. 2021, 5:e10558. 10.1002\/jbm4.10558","journal-title":"JBMR Plus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00474.2004","article-title":"Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism","volume":"289","author":"Shimada T","year":"2005","unstructured":"Shimada T, Yamazaki Y, Takahashi M, et al.. Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. Am J Physiol Renal Physiol. 2005, 289:F1088-95. 10.1152\/ajprenal.00474.2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-018-0440-2","article-title":"Effect of continuous intravenous calcium loading on fibroblast growth factor 23 in normal and uremic rats","volume":"103","author":"Shikida Y","year":"2018","unstructured":"Shikida Y, Mizobuchi M, Inoue T, Hamada T, Ogata H, Koiwa F, Shibata T. Effect of continuous intravenous calcium loading on fibroblast growth factor 23 in normal and uremic rats. Calcif Tissue Int. 2018, 103:455-64. 10.1007\/s00223-018-0440-2","journal-title":"Calcif Tissue Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108497","article-title":"Direct stimulation of bone resorption by thyroid hormones","volume":"58","author":"Mundy GR","year":"1976","unstructured":"Mundy GR, Shapiro JL, Bandelin JG, Canalis EM, Raisz LG. Direct stimulation of bone resorption by thyroid hormones. J Clin Invest. 1976, 58:529-34. 10.1172\/JCI108497","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-1947","article-title":"Prevalence of hyperthyroidism with hypercalcemia in Xindu district and the efficacy of vitamin D3 treatment in these patients: a randomized trial","volume":"10","author":"Mei X","year":"2021","unstructured":"Mei X, Zeng J, Dai WX, Yang HL, Li Y, Tang MW, Qiu P. Prevalence of hyperthyroidism with hypercalcemia in Xindu district and the efficacy of vitamin D3 treatment in these patients: a randomized trial. Ann Palliat Med. 2021, 10:9640-9. 10.21037\/apm-21-1947","journal-title":"Ann Palliat Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1510055","article-title":"Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism","volume":"151","author":"Yamashita H","year":"2004","unstructured":"Yamashita H, Yamashita T, Miyamoto M, et al.. Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism. Eur J Endocrinol. 2004, 151:55-60. 10.1530\/eje.0.1510055","journal-title":"Eur J Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2498","article-title":"Fibroblast growth factor-23 in patients with Graves' disease before and after antithyroid therapy: its important role in serum phosphate regulation","volume":"90","author":"Yamashita H","year":"2005","unstructured":"Yamashita H, Yamazaki Y, Hasegawa H, et al.. Fibroblast growth factor-23 in patients with Graves' disease before and after antithyroid therapy: its important role in serum phosphate regulation. J Clin Endocrinol Metab. 2005, 90:4211-5. 10.1210\/jc.2004-2498","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-33-6-992","article-title":"Competitive protein-binding radioassay for 25-hydroxycholecalciferol","volume":"33","author":"Haddad JG","year":"1971","unstructured":"Haddad JG, Chyu KJ. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab. 1971, 33:992-5. 10.1210\/jcem-33-6-992","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-58-1-91","article-title":"A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies","volume":"58","author":"Reinhardt TA","year":"1984","unstructured":"Reinhardt TA, Horst RL, Orf JW, Hollis BW. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab. 1984, 58:91-8. 10.1210\/jcem-58-1-91","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki Y","year":"2002","unstructured":"Yamazaki Y, Okazaki R, Shibata M, et al.. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab. 2002, 87:4957-60. 10.1210\/jc.2002-021105","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2007.00519.x","article-title":"Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases","volume":"11","author":"Imanishi Y","year":"2007","unstructured":"Imanishi Y, Kobayashi K, Kawata T, Inaba M, Nishizawa Y. Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases. Ther Apher Dial. 2007, 11:S32-7. 10.1111\/j.1744-9987.2007.00519.x","journal-title":"Ther Apher Dial"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0523","article-title":"Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?","volume":"166","author":"Witteveen JE","year":"2012","unstructured":"Witteveen JE, van Lierop AH, Papapoulos SE, Hamdy NA. Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?. Eur J Endocrinol. 2012, 166:55-60. 10.1530\/EJE-11-0523","journal-title":"Eur J Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.992666","article-title":"PTH, FGF-23, klotho and Vitamin D as regulators of calcium and phosphorus: genetics, epigenetics and beyond","volume":"13","author":"Portales-Castillo I","year":"2022","unstructured":"Portales-Castillo I, Simic P. PTH, FGF-23, klotho and Vitamin D as regulators of calcium and phosphorus: genetics, epigenetics and beyond. Front Endocrinol (Lausanne). 2022, 13:992666. 10.3389\/fendo.2022.992666","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2024.1978","article-title":"Roles of parathyroid hormone and fibroblast growth factor 23 in advanced chronic kidney disease","volume":"39","author":"Nakagawa Y","year":"2024","unstructured":"Nakagawa Y, Komaba H. Roles of parathyroid hormone and fibroblast growth factor 23 in advanced chronic kidney disease. Endocrinol Metab (Seoul). 2024, 39:407-15. 10.3803\/EnM.2024.1978","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/BF00410200","article-title":"Thyroid hormone stimulation of Na\/Pi-cotransport in opossum kidney cells","volume":"431","author":"Sorribas V","year":"1995","unstructured":"Sorribas V, Markovich D, Verri T, Biber J, Murer H. Thyroid hormone stimulation of Na\/Pi-cotransport in opossum kidney cells. Pflugers Arch. 1995, 431:266-71. 10.1007\/BF00410200","journal-title":"Pflugers Arch"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.935821","article-title":"A review of current clinical concepts in the pathophysiology, etiology, diagnosis, and management of hypercalcemia","volume":"28","author":"Tonon CR","year":"2022","unstructured":"Tonon CR, Silva TA, Pereira FW, et al.. A review of current clinical concepts in the pathophysiology, etiology, diagnosis, and management of hypercalcemia. Med Sci Monit. 2022, 28:e935821. 10.12659\/MSM.935821","journal-title":"Med Sci Monit"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-024-02848-4","article-title":"A prospective cross-sectional study on hypocalcemia after total thyroidectomy in patients with Graves' disease: insights on secondary hyperparathyroidism","volume":"54","author":"Yamashita H","year":"2024","unstructured":"Yamashita H, Sato S, Shindo H, et al.. A prospective cross-sectional study on hypocalcemia after total thyroidectomy in patients with Graves' disease: insights on secondary hyperparathyroidism. Surg Today. 2024, 54:1058-66. 10.1007\/s00595-024-02848-4","journal-title":"Surg Today"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1360464","article-title":"Significant role of 1,25-dihydroxyvitamin D on serum calcium levels after total thyroidectomy: a prospective cohort study","volume":"15","author":"Yamashita H","year":"2024","unstructured":"Yamashita H, Mori Y, Sato S, et al.. Significant role of 1,25-dihydroxyvitamin D on serum calcium levels after total thyroidectomy: a prospective cohort study. Front Endocrinol (Lausanne). 2024, 15:1360464. 10.3389\/fendo.2024.1360464","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030442","article-title":"Post-operative permanent hypoparathyroidism and preoperative vitamin D prophylaxis","volume":"10","author":"Kannan T","year":"2021","unstructured":"Kannan T, Foster Y, Ho DJ, et al.. Post-operative permanent hypoparathyroidism and preoperative vitamin D prophylaxis. J Clin Med. 2021, 10:442. 10.3390\/jcm10030442","journal-title":"J Clin Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-022-07791-z","article-title":"The role of preoperative vitamin D and calcium in preventing post-thyroidectomy hypocalcaemia: a systematic review","volume":"280","author":"Casey C","year":"2023","unstructured":"Casey C, Hopkins D. The role of preoperative vitamin D and calcium in preventing post-thyroidectomy hypocalcaemia: a systematic review. Eur Arch Otorhinolaryngol. 2023, 280:1555-63. 10.1007\/s00405-022-07791-z","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/391556-serum-calcium-as-a-determinant-of-fibroblast-growth-factor-23-levels-in-patients-with-primary-hyperparathyroidism-and-graves-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:56:32Z","timestamp":1759794992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/391556-serum-calcium-as-a-determinant-of-fibroblast-growth-factor-23-levels-in-patients-with-primary-hyperparathyroidism-and-graves-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.93972","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,6]]}}}